Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Evidence of Subcutaneous Tissue Lipolysis Enhancement by Endogenous Cortisol in Critically Ill Patients Without Shock.

Ilias I, Tzanela M, Nikitas N, Vassiliadi DA, Theodorakopoulou M, Apollonatou S, Tsagarakis S, Dimopoulou I.

In Vivo. 2015 Jul-Aug;29(4):497-9. Erratum in: In Vivo. 2015 Sep-Oct;29(5):617.

PMID:
26130795
2.

Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers.

Frantzeskaki FG, Karampi ES, Kottaridi C, Alepaki M, Routsi C, Tzanela M, Vassiliadi DA, Douka E, Tsaousi S, Gennimata V, Ilias I, Nikitas N, Armaganidis A, Karakitsos P, Papaevangelou V, Dimopoulou I.

J Crit Care. 2015 Apr;30(2):276-81. doi: 10.1016/j.jcrc.2014.10.002.

PMID:
25457114
3.

Yeast central nervous system infection in a critically ill patient: a case report.

Frantzeskaki F, Diakaki C, Rizos M, Theodorakopoulou M, Papadopoulos P, Antonopoulou A, Nikitas N, Lignos M, Brountzos E, Velegraki A, Paramythiotou E, Panagyotides J, Armaganidis A, Dimopoulos G.

J Med Case Rep. 2014 Jul 15;8:253. doi: 10.1186/1752-1947-8-253.

4.

Adipose tissue lipolysis and circulating lipids in acute and subacute critical illness: effects of shock and treatment.

Ilias I, Vassiliadi DA, Theodorakopoulou M, Boutati E, Maratou E, Mitrou P, Nikitas N, Apollonatou S, Dimitriadis G, Armaganidis A, Dimopoulou I.

J Crit Care. 2014 Dec;29(6):1130.e5-9. doi: 10.1016/j.jcrc.2014.06.003.

PMID:
25012960
5.

Coronary flow reserve is associated with tissue ischemia and is an additive predictor of intensive care unit mortality to traditional risk scores in septic shock.

Ikonomidis I, Makavos G, Nikitas N, Paraskevaidis I, Diamantakis A, Kopterides P, Theodorakopoulou M, Parissis J, Lekakis J, Armaganidis A, Dimopoulou I.

Int J Cardiol. 2014 Mar 1;172(1):103-8. doi: 10.1016/j.ijcard.2013.12.155.

PMID:
24447732
6.

L-asparaginase fatal toxic encephalopathy during consolidation treatment in an adult with acute lymphoblastic leukemia.

Frantzeskaki F, Rizos M, Papathanassiou M, Nikitas N, Lerikou M, Armaganidis A, Dimopoulos G.

Am J Case Rep. 2013 Aug 14;14:311-4. doi: 10.12659/AJCR.889268.

7.

Endothelial protein C receptor polymorphisms and risk of severe sepsis in critically ill patients.

Vassiliou AG, Maniatis NA, Kotanidou A, Kallergi M, Karystinaki FS, Letsiou E, Glynos C, Kopterides P, Vassiliadi D, Nikitas N, Dimopoulou I, Armaganidis A, Orfanos SE.

Intensive Care Med. 2013 Oct;39(10):1752-9. doi: 10.1007/s00134-013-3018-5.

PMID:
23881209
8.

Elevated adipose tissue lactate to pyruvate (L/P) ratio predicts poor outcome in critically ill patients with septic shock: a microdialysis study.

Nikitas N, Kopterides P, Ilias I, Theodorakopoulou M, Vassiliadi DA, Armaganidis A, Dimopoulou I.

Minerva Anestesiol. 2013 Nov;79(11):1229-37.

PMID:
23857439
9.

Association of ERCC1 SNPs with outcome in platinum-treated patients with advanced urothelial cancer: a Hellenic Cooperative Oncology Group study.

Nikitas N, Karadimou A, Tsitoura E, Soupos N, Tsiatas M, Karavasilis V, Pectasides D, Pavlidis N, Chrisofos M, Adamakis I, Murray S, Fountzilas G, Dimopoulos MA, Bamias A.

Pharmacogenomics. 2012 Nov;13(14):1595-607. doi: 10.2217/pgs.12.162.

PMID:
23148636
10.

Interrelationship between blood and tissue lactate in a general intensive care unit: a subcutaneous adipose tissue microdialysis study on 162 critically ill patients.

Kopterides P, Theodorakopoulou M, Ilias I, Nikitas N, Frantzeskaki F, Vassiliadi DA, Armaganidis A, Dimopoulou I.

J Crit Care. 2012 Dec;27(6):742.e9-18. doi: 10.1016/j.jcrc.2012.08.003.

PMID:
23089678
11.

Interstitial cortisol obtained by microdialysis in mechanically ventilated septic patients: correlations with total and free serum cortisol.

Vassiliadi DA, Ilias I, Tzanela M, Nikitas N, Theodorakopoulou M, Kopterides P, Maniatis N, Diamantakis A, Orfanos SE, Perogamvros I, Armaganidis A, Keevil BG, Tsagarakis S, Dimopoulou I.

J Crit Care. 2013 Apr;28(2):158-65. doi: 10.1016/j.jcrc.2012.07.008.

PMID:
22981531
12.

Red blood cell transfusion affects microdialysis-assessed interstitial lactate/pyruvate ratio in critically ill patients with late sepsis.

Kopterides P, Theodorakopoulou M, Nikitas N, Ilias I, Vassiliadi DA, Orfanos SE, Tsangaris I, Maniatis NA, Tsantes AE, Travlou A, Dimitriadis G, Armaganidis A, Ungerstedt U, Dimopoulou I.

Intensive Care Med. 2012 Nov;38(11):1843-50. doi: 10.1007/s00134-012-2635-8.

PMID:
22777518
13.

The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma.

Dimopoulos MA, Roussou M, Gkotzamanidou M, Nikitas N, Psimenou E, Mparmparoussi D, Matsouka C, Spyropoulou-Vlachou M, Terpos E, Kastritis E.

Leukemia. 2013 Feb;27(2):423-9. doi: 10.1038/leu.2012.182.

PMID:
22763386
14.

XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis.

Pectasides D, Papaxoinis G, Kalogeras KT, Eleftheraki AG, Xanthakis I, Makatsoris T, Samantas E, Varthalitis I, Papakostas P, Nikitas N, Papandreou CN, Pentheroudakis G, Timotheadou E, Koutras A, Sgouros J, Bafaloukos D, Klouvas G, Economopoulos T, Syrigos KN, Fountzilas G.

BMC Cancer. 2012 Jun 29;12:271. doi: 10.1186/1471-2407-12-271.

15.

Serial changes in adiponectin and resistin in critically ill patients with sepsis: associations with sepsis phase, severity, and circulating cytokine levels.

Vassiliadi DA, Tzanela M, Kotanidou A, Orfanos SE, Nikitas N, Armaganidis A, Koutsilieris M, Roussos C, Tsagarakis S, Dimopoulou I.

J Crit Care. 2012 Aug;27(4):400-9. doi: 10.1016/j.jcrc.2012.04.007.

PMID:
22699030
16.

Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.

Razis E, Kalogeras KT, Kotoula V, Eleftheraki AG, Nikitas N, Kronenwett R, Timotheadou E, Christodoulou C, Pectasides D, Gogas H, Wirtz RM, Makatsoris T, Bafaloukos D, Aravantinos G, Televantou D, Pavlidis N, Fountzilas G.

Clin Breast Cancer. 2012 Jun;12(3):183-93. doi: 10.1016/j.clbc.2012.03.006. Erratum in: Clin Breast Cancer. 2012 Oct;12(5):386.

PMID:
22607768
17.

Increased expression of cyclin-D1 on trephine bone marrow biopsies independently predicts for shorter overall survival in patients with multiple myeloma treated with novel agents.

Tasidou A, Roussou M, Terpos E, Kastritis E, Gkotzamanidou M, Gavriatopoulou M, Migkou M, Eleutherakis-Papaiakovou E, Nikitas N, Anagnostou D, Dimopoulos MA.

Am J Hematol. 2012 Jul;87(7):734-6. doi: 10.1002/ajh.23223.

18.

A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis.

Kastritis E, Terpos E, Roussou M, Gavriatopoulou M, Pamboukas C, Boletis I, Marinaki S, Apostolou T, Nikitas N, Gkortzolidis G, Michalis E, Delimpasi S, Dimopoulos MA.

Blood. 2012 Jun 7;119(23):5384-90. doi: 10.1182/blood-2011-12-396903.

19.

Renal impairment is not an independent adverse prognostic factor in patients with multiple myeloma treated upfront with novel agent-based regimens.

Eleftherakis-Papapiakovou E, Kastritis E, Roussou M, Gkotzamanidou M, Grapsa I, Psimenou E, Nikitas N, Terpos E, Dimopoulos MA.

Leuk Lymphoma. 2011 Dec;52(12):2299-303. doi: 10.3109/10428194.2011.597906.

PMID:
22141916
20.

Increased serum lactate dehydrongenase should be included among the variables that define very-high-risk multiple myeloma.

Gkotzamanidou M, Kastritis E, Gavriatopoulou MR, Nikitas N, Gika D, Mparmparousi D, Matsouka C, Terpos E, Dimopoulos MA.

Clin Lymphoma Myeloma Leuk. 2011 Oct;11(5):409-13. doi: 10.1016/j.clml.2011.07.001.

PMID:
21903504
Items per page

Supplemental Content

Loading ...
Support Center